CA116-003
Install Now
CA116-003
CA116-003

CA116-003

Application for participants in Bristol Myers Squibb CA116-003 study.

Developer: Medable Inc.
App Size: Varies With Device
Release Date: Oct 18, 2022
Price: Free
Price
Free
Size
Varies With Device

Screenshots for App

Mobile
You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms.
Show More
Show Less
CA116-003 v1.0.0 Update
2022-10-19 Version History
Initial release

~Medable Inc.
More Information about: CA116-003
Price: Free
Version: v1.0.0
Downloads: 8
Compatibility: Android 6.0
Bundle Id: com.medable.bms.ca116003
Size: Varies With Device
Last Update: 2022-10-19
Content Rating: Everyone
Release Date: Oct 18, 2022
Content Rating: Everyone
Developer: Medable Inc.


Whatsapp
Vkontakte
Telegram
Reddit
Pinterest
Linkedin
Hide